Vigene Biosciences

Jeffrey Hung, Ph.D., Chief Commercial Officer
Rockville, MD
(Private)
Vigene Biosciences is an awarding winning world leader in plasmid and viral vector development and manufacturing. Vigene features integrated plasmid and viral vector production and analytical service offerings from its 71,000 sq. ft. of start-of-the-art facility with 10 GMP cleanroom suites. Vigene’s mission is to make gene therapy affordable. On the basic research side, Vigene is developing, manufacturing, and distributing state-of-the-art AAV, lentivirus, retrovirus, adenovirus, and plasmid based reagents including HHMI/Janelia Research Campus AAV Biosensors. On the cGMP clinical production side, Vigene combines the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical and commercial material clients. Vigene offers FDA and EMA compliant cGMP production for AAV, lentivirus, adenovirus, retrovirus, and plasmids to global pharmaceutical and biotech companies, governmental agencies, and non-profit organization.
www.vigenebio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions